You have a lot to protect, bank more than cord blood.

The Value of Stem Cells

Stem cells can actually be used to replace other cells in the body that are abnormal or have been destroyed by disease.1 In fact, stem cell transplants have already become the standard of care for many life-threatening blood disorders.2-6

Transplants using cord blood stem cells - more than 20 years of history

The first cord blood stem cell transplant was performed in Paris in 1988. The patient was a 5-year-old boy with Fanconi's syndrome, a rare, serious type of anemia.7 The transplant was a success - and the patient is a healthy adult today. Since that first transplant, cord blood stem cell transplants have been used to treat at least 80 different diseases.7,8

Leukemia, lymphoma, and myeloma - 3 diseases commonly treated with stem cells9

  • Leukemia is the most common cancer in American children, with almost 45,000 new cases diagnosed in 2009 alone.9
  • About 75,000 new cases of lymphoma were diagnosed in the U.S. alone in 2009.9
  • More than 20,000 new cases of myeloma were diagnosed in the U.S. alone in 2009.9

Stem cells - impacting real families, like yours, right now

When you bank your baby's stem cells with LifebankUSA, you bank with experience. As a matter of fact, LifebankUSA has had more than a decade of experience in stem cell banking.

Please click here for personal stories of children whose lives have been saved by stem cell banking with LifebankUSA.

Please click here for a full list of diseases treated with stem cells from LifebankUSA.

* These are diseases for which stem cell treatments have been shown to be potentially beneficial, but additional studies are required before they can be used as standard therapy. These investigational uses are not consistent with current labeling. Stem cells from the placenta and cord blood are indicated to rebuild blood. The chance that a child will use his/her own stored stem cells during his/her lifetime for currently treated conditions is estimated at 1 in 40010. These odds may increase if there is a family history of certain blood disorders or cancers. The potential risks and benefits of stem cell transplantation vary and depend on many factors, such as the amount and quality of the stem cells collected, the HLA compatibility between recipient and donor, and the client's overall health.

† Partial list of the 80 diseases that have been treated with cord blood stem cell transplants.

‡ LifebankUSA has not yet released stem cells to treat these diseases.

References:
  1. National Institutes of Health. Stem cell basics: 1. Introduction. http://stemcells.nih.gov/info/basics/basics1. Accessed Nov 14, 2011.
  2. Schmit-Pokorny K. Expanding indications for stem cell transplantation. Semin Oncol Nurs. 2009;25(2):105-114.
  3. Moskowitz AJ, Moskowitz CH. Controversies in the treatment of lymphoma with autologous transplantation. Oncologist. 2009;14(9):921-929.
  4. Gratwohl A, Heim D. Current role of stem cell transplantation in chronic myeloid leukaemia. Best Pract Res Clin Haematol. 2009;22(3):431-443.
  5. Minnema MC, van der Spek E, van der Donk NW, Lokhorst HM. New developments in the treatment of patients with multiple myeloma. Neth J Med. 2010;68(1):24-32.
  6. Chen Y-B, Hochberg EP, Feng Y, et al. Characteristics and outcomes after autologous stem cell transplants for patients with relapsed or refractory diffuse large B-cell lymphoma who failed initial rituximab, cyclophosphamide, adriamycin, vincristine, and prednisone therapy compared to patients who failed cyclophosphamide, adriamycin, vincristine, and prednisone. Leuk Lymphoma. 2010;51(5):789-796.
  7. The Leukemia & Lymphoma Society. Cord blood stem cell transplantation. No. 2. http://www. lls.org/resourcecenter/freeeducationmaterials/treatment/cordblood Accessed November 21, 2011.
  8. St. Jude Children's Research Hospital. Diseases treated by stem cell transplant. http://www.stjude.org/stjude/v/index.jsp?vgnextoid=8beffa2454e70110VgnVCM100 0001e0215acRCRD&vgnextchannel=34cabfe82e118010VgnVCM1000000e2015acR CRD Accessed November 11, 2011.
  9. The Leukemia & Lymphoma Society. Facts 2009-2010. http://www.leukemia-lymphoma.org/all_mat_toc.adp?item_id=481790. Accessed Nov 14, 2011.
  10. Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant. 2008;14(3):316-322.